The characteristic structure contains clusters of microcrystals of predominantly anhydrous ß-lactose, resulting in low-moisture content. The unique, low levels of crystalline water make the use of SuperTab® 21AN with PAT technologies efficient. Its strong fragmentation behavior, combined with microcrystal aggregates, ensures the excellent compactability of SuperTab® 21AN.
Part of a portfolio offering enhanced functionality
DFE Pharma offers an extensive anhydrous portfolio, with different particle sizes and morphology, to enable the fine tuning of formulations across a wide range.
Allows excellent compaction and re- compaction.
Tablet tensile strength remains high after recompaction. Therefore SuperTab ® 21AN is the preferred choice for dry granulation processes.
Optimized in line PAT qualification for efficiency.
The unique, low levels of crystalline water (typically ~0.1% w/w) makes the use of SuperTab® 21AN with PAT technologies efficient. The low water content is a result of high controlled beta-lactose content typically >80% and absence of monohydrate lactose.
